| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +46% |
| 3Y CAGR | -2% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +156% |
| 3Y CAGR | -3% |
| Fund name | AUM% |
|---|---|
| 1.00 | |
| 0.02 |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,325.60 -50.50 (2.13%) | 17,671.58 | 26.06 | 5.24 | ||
PfizerPFIZER | ₹3,687.80 -72.00 (1.91%) | 16,867.42 | 22.94 | 4.01 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,364.50 +65.50 (1.04%) | 15,918.38 | 93.84 | 18.24 | ||
Natco PharmaNATCOPHARM | ₹782.40 -5.15 (0.65%) | 15,350.14 | 13.41 | 1.46 |